WNX
+0.0 · +0.00%
GBX · LSE

Wellnex Life Limited(WNX) Stock Analysis | Consumer Defensive

GBX --+0.00%
Reward49Moderate
Risk78High
75%Data
Thin -40% profit margin
Speculative Momentum
Market Cap:4.02M
Reward Rating
49
Moderate
Reward Assessment
75% data coverage
Bottom 50% of stocksView factors
Risk Rating
78
High
Risk Assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on WNX to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Wellnex Life Limited?

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom.

AI Brief Pro

The brief on Wellnex Life Limited

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Wellnex Life Limited?

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. The company is listed on the LSE in UK, operating in the Consumer Defensive sector, with a market capitalisation of 4.02M.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Elevated volatility implies higher downside and expectation risk.
Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (49)

Similar stocks to compare

A short list of Packaged Foods names that are close enough in size to make side-by-side comparison useful.

All Consumer Defensive stocks →
Company Information
IndustryPackaged Foods
Beta1.275
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.